Study of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC Patients
Status:
Unknown status
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to Evaluate and compare safety and efficacy of Gemcitabine
Maintenance Treatment in Patients With Extensive SCLC Patients Receiving Etoposide Combined
With Platinum Based First-line Chemotherapy